Want to join the conversation?
$JNJ's Janssen Biotech unit announced that the US FDA has approved STELARA (ustekinumab) for the treatment of moderately to severely active Crohn's disease in adults who have failed or were intolerant to treatment with immunomodulators or corticosteroids. Crohn's disease is an inflammatory disease which affects the gastrointestinal tract.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.